3B Blackbio Dx balance sheet

As of Mar 2025
Total assets
₹297cr+18.9% on Mar 2024
Shareholders' equity
₹273cr+19.8% on Mar 2024
Total debt
₹0.3cr−57.0% on Mar 2024
Cash and investments
₹6.2cr−2.7% on Mar 2024
₹ crore except per share
Tap a line for its trendFY25Mar 2025FY24Mar 2024
Non-current assets
167128
173134
Current assets
8.18.0
35.236.5
6.26.4
56.548.5
0.20.1
98.091.5
17.916.1
124116
297250
Equity
8.68.6
264219
273228
273228
Liabilities
0.30.7
0.30.7
5.84.3
6.15.0
1.63.6
0.40.4
2.04.0
14.810.8
1.42.2
18.217.0
24.322.0
297250
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

3BBLACKBIO₹1,359.20

3B Blackbio Dx Limited

· Pharma & Health
₹ CrorePeersHEALTHXSURAKSHAKRSNAANEPHROPLUS
View
In ₹ Crore except Per Share
As of
FY24
31/03/2024
FY25
31/03/2025
Non-current Assets
+ Non-current Investments127.7166.7
Total Non-current Assets134.2173.1
Current Assets
+ Inventories8.08.1
+ Trade Receivables36.535.2
+ Cash & Cash Equivalents6.46.2
+ Other Bank Balances48.556.5
+ Other Current Financial Assets0.10.2
Current Financial Assets91.598.0
+ Other Current Assets16.117.9
Total Current Assets115.6124.0
Total Assets249.8297.1
Equity
+ Equity Share Capital8.68.6
+ Other Equity / Reserves219.2264.2
Equity — Owners of Parent227.8272.8
Total Equity227.8272.8
Liabilities
+ Borrowings — Non-current0.70.3
Non-current Financial Liabilities0.70.3
+ Deferred Tax Liabilities4.35.8
Non-current Liabilities5.06.1
+ Trade Payables3.61.6
+ Other Current Financial Liab0.40.4
Current Financial Liabilities4.02.0
+ Provisions — Current10.814.8
+ Other Current Liabilities2.21.4
Current Liabilities17.018.2
Total Liabilities22.024.3
Total Equity & Liabilities249.8297.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.